Who are the LGBTQ+ lead­ers forg­ing paths in bio­phar­ma in 2022? Nom­i­nate them for an End­points spe­cial re­port

In my time re­port­ing on biotech’s queer com­mu­ni­ty, Lau­rent Fis­ch­er, Jen­nifer Buell, Gary Ur­ban and mul­ti­ple oth­er LGBTQ+ bio­phar­ma ex­ec­u­tives have told me the in­dus­try and so­ci­ety have both changed for the bet­ter since they got their starts in bio­phar­ma in the 1990s.

Paul Hast­ings, chair of BIO, said “you’d have to look re­al­ly hard” to find a ho­mo­phobe or “folks like that” in the drug de­vel­op­ment world.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER